that emerged in the UK with the second COVID-19 wave in late 2020. The efficacy of currently
licensed COVID-19 vaccines against B. 1.617. 2 is unknown; although it possesses 12 …

To evaluate these risks, we enrolled 200 patient-facing HCWs between March 26 and April 8,
2020, in SARS-CoV-2 Acquisition in Frontline Healthcare Workers—Evaluation to inform …

The SARS-CoV-2 B. 1.617. 2 Delta variant of concern (VOC) continues to drive a sharp increase
in COVID-19 cases in the UK, with a current doubling time of 3· 5–16 days, 1 consistent …

Omicron, the SARS-CoV-2 B. 1.1. 529 variant of concern (VOC), was first detected in southern
Africa in November, 2021, and its BA. 1 sublineage is now dominant in the UK. Omicron …

Light-emitting diodes (LEDs) are ubiquitous in modern society, with applications spanning
from lighting and displays to medical diagnostics and data communications. Metal-halide …

Advancements in volume electron microscopy mean it is now possible to generate thousands
of serial images at nanometre resolution overnight, yet the gold standard approach for …

To the Editor—The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
1–3 has led to a pandemic infecting more than seven million people worldwide in …

In this cohort study, we aim to compare outcomes from coronavirus disease 2019 (COVID-19)
in people with severe epilepsy and other co-morbidities living in long-term care facilities …

An important component of the UK’s early response to the COVID-19 pandemic was increasing
SARS-CoV-2 testing capacity across the National Health Service (NHS). At the time, we …

The ongoing pandemic of SARS-CoV-2 calls for rapid and cost-effective methods to accurately
identify infected individuals. The vast majority of patient samples is assessed for viral …